Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

233 studies match

clinicaltrialsPublishedShowing 1–50 of 233 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05006716	A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies(CaDAnCe-101)	recruiting	Phase 1 / Phase 2	645	BeOne MedicinesINDUSTRY	16	Sep 28, 2026	clinicaltrials
NCT05100862	A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma(MAHOGANY)	active not recruiting	Phase 3	799	BeOne MedicinesINDUSTRY